Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma

Anne Rombaut, Rune Brautaset, Pete A. Williams, James R. Tribble

Open source

DOI
10.1186/s13041-024-01160-z
Published
2024-11-22
Container
Molecular Brain
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13041-024-01160-z,
  title = {Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma},
  author = {Anne Rombaut and Rune Brautaset and Pete A. Williams and James R. Tribble},
  year = {2024},
  journal = {Molecular Brain},
  doi = {10.1186/s13041-024-01160-z},
  url = {https://doi.org/10.1186/s13041-024-01160-z}
}

RIS

TY  - JOUR
TI  - Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
AU  - Anne Rombaut
AU  - Rune Brautaset
AU  - Pete A. Williams
AU  - James R. Tribble
PY  - 2024
JO  - Molecular Brain
DO  - 10.1186/s13041-024-01160-z
UR  - https://doi.org/10.1186/s13041-024-01160-z
ER  - 

APA

Rombaut, A., Brautaset, R., Williams, P. A., & Tribble, J. R. (2024). Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma. Molecular Brain. https://doi.org/10.1186/s13041-024-01160-z

Source records